Evidence map›Paper›PMID 34792264›Full record

Trial reportNeurogastroenterology and motility2022

Effect of amino acid-based formula added to four-food elimination in adult eosinophilic esophagitis patients: A randomized clinical trial.

Willemijn E de Rooij, Berber Vlieg-Boerstra, Marijn J Warners, Marleen T J Van Ampting, Betty C A M van Esch, Simone R B M Eussen, Albert J Bredenoord

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neurogastroenterology and motility, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Medical treatment of eosinophilic esophagitis.The Cochrane database of systematic reviews · 2023
    Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Willemijn E de RooijDepartment of Gastroenterology & Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-1691-6270
Berber Vlieg-BoerstraDepartment of Paediatrics, OLVG, Amsterdam, The Netherlands.
Marijn J WarnersDepartment of Gastroenterology & Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Marleen T J Van AmptingDanone Nutricia Research, Utrecht, The Netherlands.
Betty C A M van EschDanone Nutricia Research, Utrecht, The Netherlands.
Simone R B M EussenDanone Nutricia Research, Utrecht, The Netherlands.
Albert J BredenoordDepartment of Gastroenterology & Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLDanone (Netherlands) · NLHanze University of Applied Sciences · NLUniversity Medical Center Utrecht · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElimination of key foods restricts dietary options in eosinophilic esophagitis (EoE) patients. Addition of amino acid-based formula (AAF) to an elimination diet might facilitate adherence and, therefore, enhance efficacy of dietary management.

aimTo evaluate whether addition of AAF to a four-food elimination diet (FFED) is more effective than FFED alone in decreasing eosinophilia, endoscopic signs, and clinical outcomes.

methodsThis randomized controlled trial enrolled 41 adult patients with active EoE (≥15 eosinophils (eos) per high power field (hpf)) at baseline biopsy. Subjects were randomized (1:1 ratio) to groups given a FFED or FFED with addition of AAF providing 30% of their daily energy needs (FFED + AAF). Histological disease activity, endoscopic signs, symptoms, and disease-related quality of life (EoEQoL) were measured at baseline and after 6 weeks of intervention.

resultsPatients (60% male, age 34.5 (interquartile range (IQR) 29-42.8 years)) were randomized to FFED (n = 20) or FFED + AAF (n = 21); 40 participants completed the diet. Complete histological remission (<15 eos/hpf) was achieved in 48% of FFED + AAF subjects (n = 21) vs. 25% of FFED subjects (n = 20), respectively (p = 0.204). Peak eosinophil counts (PEC) decreased significantly in both groups between baseline and week 6, but the change in PEC between groups was not different (p = 0.130). A significant but similar endoscopic and symptomatic reduction was observed in both groups (all; p<0.05). Total EoEQoL scores significantly improved in the FFED + AAF group between baseline and week 6 (p = 0.007), and not in the FFED group.

conclusionThe addition of AAF to a FFED did not lead to a larger decrease in PEC between baseline and 6 weeks, but may result in a significant improvement of QoL in adult EoE patients NL6014 (NTR6778).

Indexed as

Eosinophilic EsophagitisAdultAmino AcidsEnteritisEosinophiliaEosinophilsFemaleGastritisHumansMaleQuality of LifeAmino Acidselemental dietelimination dieteosinophilic esophagitisesophageal eosinophilia and allergyquality of life

Identifiers

PMID34792264
PMCPMC9286809
OpenAlexW3214230689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.